TheJakartaPost

Please Update your browser

Your browser is out of date, and may not be compatible with our website. A list of the most popular web browsers can be found below.
Just click on the icons to get to the download page.

Jakarta Post

US narrowing support to seven COVID-19 vaccine candidates, expects them to be free for many

News Desk (Reuters)
Wed, June 17, 2020 Published on Jun. 17, 2020 Published on 2020-06-17T08:53:43+07:00

Change text size

Gift Premium Articles
to Anyone

Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!
US narrowing support to seven COVID-19 vaccine candidates, expects them to be free for many A researcher at the University of Pittsburgh works on a COVID-19 vaccine candidate, a fingertip-sized patch with dissolvable microscopic needles, in Pittsburgh, Pennsylvania, US March 28, 2020. The Trump administration aims to narrow its financial support to about seven experimental coronavirus vaccines from the 14 it has been working with so far, the US Department of Health and Human Services (HHS) said on Tuesday. (Reuters/ UPMC/Handout )

T

he Trump administration aims to narrow its financial support to about seven experimental coronavirus vaccines from the 14 it has been working with so far, the US Department of Health and Human Services (HHS) said on Tuesday.

US government officials also said that they expect many Americans to get an approved vaccine to prevent COVID-19 at no charge once it begins distribution, potentially in January.

“For any American who is vulnerable, who cannot afford the vaccines, and desires the vaccine, we will provide it for free,” a US government official said during a call with reporters, requesting anonymity.

The official also said that based on conversations with commercial health insurers, it expects a vaccine to be covered with no out-of-pocket costs, similar to coverage policies insurers have put in place for COVID-19 related medical services.

"We will be working with insurers," the official said.

The Trump Administration last month launched "Operation Warp Speed" - a joint HHS and Department of Defense program - to accelerate development of coronavirus vaccines, treatments and diagnostics.

The effort has "maximized the possibility" of having a vaccine before year end, the government official said.

The Trump Administration previously announced it has put more than $2 billion behind three vaccines in development, one being tested by AstraZeneca Plc along with the University of Oxford, a Moderna Inc candidate and one from Johnson & Johnson. It has also given more than $30 million each to Merck & Co and Sanofi SA for their separate vaccine efforts.

A government official said it was still deliberating which companies would ultimately be among those it will support, based on the success of closely watched trials and manufacturing capability.

The New York Times reported earlier this month that the White House had selected five companies: Moderna, AstraZeneca, Pfizer Inc, J&J and Merck. 

 

Your Opinion Matters

Share your experiences, suggestions, and any issues you've encountered on The Jakarta Post. We're here to listen.

Enter at least 30 characters
0 / 30

Thank You

Thank you for sharing your thoughts. We appreciate your feedback.

Share options

Quickly share this news with your network—keep everyone informed with just a single click!

Change text size options

Customize your reading experience by adjusting the text size to small, medium, or large—find what’s most comfortable for you.

Gift Premium Articles
to Anyone

Share the best of The Jakarta Post with friends, family, or colleagues. As a subscriber, you can gift 3 to 5 articles each month that anyone can read—no subscription needed!

Continue in the app

Get the best experience—faster access, exclusive features, and a seamless way to stay updated.